Drug Profile
P 3085
Alternative Names: P-3085Latest Information Update: 16 Feb 2022
Price :
$50
*
At a glance
- Originator Polichem
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Psoriasis
Most Recent Events
- 16 Feb 2022 Discontinued - Phase-II for Psoriasis in European Union (unspecified route) (Polichem and Almirall pipeline, February 2022)
- 30 May 2016 Phase-II clinical trials in Psoriasis in European Union (unspecified route) before May 2016